JPY 2984.0
(0.47%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 36.46 Billion JPY | -2.79% |
2022 | 37.5 Billion JPY | -1.45% |
2021 | 38.06 Billion JPY | 9.27% |
2020 | 34.83 Billion JPY | 7.22% |
2019 | 32.48 Billion JPY | 2.23% |
2018 | 31.77 Billion JPY | 2.09% |
2017 | 31.12 Billion JPY | 2.15% |
2016 | 30.47 Billion JPY | 0.14% |
2015 | 30.42 Billion JPY | 1.21% |
2014 | 30.06 Billion JPY | 6.41% |
2013 | 28.25 Billion JPY | 0.84% |
2012 | 28.01 Billion JPY | -0.61% |
2011 | 28.18 Billion JPY | 20.69% |
2010 | 23.35 Billion JPY | 2.7% |
2009 | 22.74 Billion JPY | -0.54% |
2008 | 22.86 Billion JPY | 6.32% |
2007 | 21.5 Billion JPY | -4.06% |
2006 | 22.41 Billion JPY | 6.7% |
2005 | 21 Billion JPY | 3.61% |
2004 | 20.27 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 9.4 Billion JPY | 5.06% |
2023 Q3 | 9.02 Billion JPY | -0.53% |
2023 Q4 | 8.95 Billion JPY | -0.8% |
2023 FY | 36.46 Billion JPY | -2.79% |
2023 Q2 | 9.07 Billion JPY | -3.46% |
2023 Q1 | 9.4 Billion JPY | 3.65% |
2022 Q3 | 9.66 Billion JPY | 3.33% |
2022 Q2 | 9.35 Billion JPY | -0.83% |
2022 Q1 | 9.42 Billion JPY | -7.53% |
2022 FY | 37.5 Billion JPY | -1.45% |
2022 Q4 | 9.07 Billion JPY | -6.12% |
2021 Q4 | 10.19 Billion JPY | 12.9% |
2021 FY | 38.06 Billion JPY | 9.27% |
2021 Q1 | 9.22 Billion JPY | -7.36% |
2021 Q2 | 9.6 Billion JPY | 4.1% |
2021 Q3 | 9.03 Billion JPY | -5.99% |
2020 Q4 | 9.96 Billion JPY | 17.92% |
2020 FY | 34.83 Billion JPY | 7.22% |
2020 Q2 | 8.24 Billion JPY | 0.75% |
2020 Q3 | 8.44 Billion JPY | 2.49% |
2020 Q1 | 8.18 Billion JPY | 1.0% |
2019 Q1 | 8.17 Billion JPY | 4.01% |
2019 FY | 32.48 Billion JPY | 2.23% |
2019 Q4 | 8.1 Billion JPY | -0.75% |
2019 Q3 | 8.16 Billion JPY | 1.35% |
2019 Q2 | 8.05 Billion JPY | -1.49% |
2018 Q2 | 7.83 Billion JPY | -3.65% |
2018 Q3 | 7.95 Billion JPY | 1.63% |
2018 Q4 | 7.85 Billion JPY | -1.26% |
2018 FY | 31.77 Billion JPY | 2.09% |
2018 Q1 | 8.12 Billion JPY | 5.7% |
2017 Q3 | 7.84 Billion JPY | 2.11% |
2017 FY | 31.12 Billion JPY | 2.15% |
2017 Q2 | 7.68 Billion JPY | -2.85% |
2017 Q1 | 7.9 Billion JPY | 4.95% |
2017 Q4 | 7.69 Billion JPY | -1.98% |
2016 Q3 | 7.55 Billion JPY | -1.37% |
2016 Q1 | 7.73 Billion JPY | 2.62% |
2016 Q2 | 7.65 Billion JPY | -0.97% |
2016 Q4 | 7.53 Billion JPY | -0.2% |
2016 FY | 30.47 Billion JPY | 0.14% |
2015 Q3 | 7.52 Billion JPY | -0.67% |
2015 Q4 | 7.53 Billion JPY | 0.07% |
2015 FY | 30.42 Billion JPY | 1.21% |
2015 Q1 | 7.78 Billion JPY | 3.84% |
2015 Q2 | 7.57 Billion JPY | -2.66% |
2014 Q2 | 7.57 Billion JPY | 0.3% |
2014 Q1 | 7.55 Billion JPY | 5.9% |
2014 FY | 30.06 Billion JPY | 6.41% |
2014 Q4 | 7.49 Billion JPY | 0.78% |
2014 Q3 | 7.44 Billion JPY | -1.77% |
2013 Q1 | 7.07 Billion JPY | 3.74% |
2013 Q2 | 7.01 Billion JPY | -0.75% |
2013 Q4 | 7.13 Billion JPY | 1.34% |
2013 FY | 28.25 Billion JPY | 0.84% |
2013 Q3 | 7.03 Billion JPY | 0.27% |
2012 Q4 | 6.81 Billion JPY | -3.0% |
2012 FY | 28.01 Billion JPY | -0.61% |
2012 Q3 | 7.02 Billion JPY | 0.64% |
2012 Q2 | 6.98 Billion JPY | -2.97% |
2012 Q1 | 7.19 Billion JPY | -0.42% |
2011 Q2 | 6.97 Billion JPY | -3.02% |
2011 FY | 28.18 Billion JPY | 20.69% |
2011 Q4 | 7.22 Billion JPY | 6.44% |
2011 Q3 | 6.78 Billion JPY | -2.74% |
2011 Q1 | 7.19 Billion JPY | 25.37% |
2010 Q1 | 5.87 Billion JPY | 4.61% |
2010 FY | 23.35 Billion JPY | 2.7% |
2010 Q4 | 5.74 Billion JPY | -2.18% |
2010 Q3 | 5.86 Billion JPY | -0.12% |
2010 Q2 | 5.87 Billion JPY | -0.05% |
2009 Q3 | 5.71 Billion JPY | 1.94% |
2009 Q2 | 5.6 Billion JPY | -3.41% |
2009 Q1 | 5.8 Billion JPY | 5.38% |
2009 FY | 22.74 Billion JPY | -0.54% |
2009 Q4 | 5.61 Billion JPY | -1.7% |
2008 Q4 | 5.5 Billion JPY | -4.8% |
2008 FY | 22.86 Billion JPY | 6.32% |
2008 Q2 | 5.74 Billion JPY | 0.0% |
2008 Q3 | 5.78 Billion JPY | 0.67% |
2007 FY | 21.5 Billion JPY | -4.06% |
2006 FY | 22.41 Billion JPY | 6.7% |
2005 FY | 21 Billion JPY | 3.61% |
2004 FY | 20.27 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 9.85 Billion JPY | -269.83% |
DNA Chip Research Inc. | 324.19 Million JPY | -11146.592% |
Cosmo Bio Company,Limited | 2.73 Billion JPY | -1235.079% |
H.U. Group Holdings, Inc. | 67.27 Billion JPY | 45.805% |
FALCO HOLDINGS Co., Ltd. | 10.77 Billion JPY | -238.511% |
Human Metabolome Technologies, Inc. | 639.4 Million JPY | -5602.359% |
Precision System Science Co., Ltd. | 1.9 Billion JPY | -1812.335% |